Loss of NECTIN1 triggers melanoma dissemination upon local IGF1 depletion.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
12 2022
Historique:
received: 22 07 2021
accepted: 24 08 2022
pubmed: 14 10 2022
medline: 15 12 2022
entrez: 13 10 2022
Statut: ppublish

Résumé

Cancer genetics has uncovered many tumor-suppressor and oncogenic pathways, but few alterations have revealed mechanisms involved in tumor spreading. Here, we examined the role of the third most significant chromosomal deletion in human melanoma that inactivates the adherens junction gene NECTIN1 in 55% of cases. We found that NECTIN1 loss stimulates melanoma cell migration in vitro and spreading in vivo in both zebrafish and human tumors specifically in response to decreased IGF1 signaling. In human melanoma biopsy specimens, adherens junctions were seen exclusively in areas with low IGF1 levels, but not in NECTIN1-deficient tumors. Our study establishes NECTIN1 as a major determinant of melanoma dissemination and uncovers a genetic control of the response to microenvironmental signals.

Identifiants

pubmed: 36229674
doi: 10.1038/s41588-022-01191-z
pii: 10.1038/s41588-022-01191-z
pmc: PMC9729115
doi:

Substances chimiques

IGF1 protein, human 0
Insulin-Like Growth Factor I 67763-96-6

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1839-1852

Subventions

Organisme : NCI NIH HHS
ID : K99 CA201465
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA163222
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA103846
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022. The Author(s).

Références

Steeg, P. S. Targeting metastasis. Nat. Rev. Cancer 16, 201–218 (2016).
doi: 10.1038/nrc.2016.25
Schadendorf, D. et al. Melanoma. Lancet 392, 971–984 (2018).
doi: 10.1016/S0140-6736(18)31559-9
Kim, M. et al. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 125, 1269–1281 (2006).
doi: 10.1016/j.cell.2006.06.008
Yachida, S. et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114–1117 (2010).
doi: 10.1038/nature09515
Turajlic, S. et al. Tracking cancer evolution reveals constrained routes to metastases: TRACERx Renal. Cell 173, 581–594 (2018).
doi: 10.1016/j.cell.2018.03.057
Reiter, J. G. et al. Minimal functional driver gene heterogeneity among untreated metastases. Science 361, 1033–1037 (2018).
doi: 10.1126/science.aat7171
Priestley, P. et al. Pan-cancer whole-genome analyses of metastatic solid tumours. Nature 575, 210–216 (2019).
doi: 10.1038/s41586-019-1689-y
McAllister, S. S. & Weinberg, R. A. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat. Cell Biol. 16, 717–727 (2014).
doi: 10.1038/ncb3015
Vanharanta, S. & Massagué, J. Origins of metastatic traits. Cancer Cell 24, 410–421 (2013).
doi: 10.1016/j.ccr.2013.09.007
Cavallaro, U. & Christofori, G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer 4, 118–132 (2004).
doi: 10.1038/nrc1276
Peri, A. K., Wilgenbus, P., Dahl, U., Semb, H. & Christofori, G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392, 190–193 (1998).
doi: 10.1038/32433
Nieto, M. A., Huang, R. Y. Y. J., Jackson, R. A. A. & Thiery, J. P. P. EMT: 2016. Cell 166, 21–45 (2016).
doi: 10.1016/j.cell.2016.06.028
Dongre, A. & Weinberg, R. A. New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell Biol. 20, 69–84 (2019).
doi: 10.1038/s41580-018-0080-4
Mort, R. L., Jackson, I. J. & Elizabeth Patton, E. The melanocyte lineage in development and disease. Development 142, 620–632 (2015).
doi: 10.1242/dev.106567
Hsu, M. Y. et al. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am. J. Pathol. 156, 1515–1525 (2000).
doi: 10.1016/S0002-9440(10)65023-7
Hsu, M. Y. Shifts in cadherin profiles between human normal melanocytes and melanomas. J. Investig. Dermatol. Symp. Proc. 1, 188–194 (1996).
Takahashi, K. et al. Nectin/PRR: An immunoglobulin-like cell adhesion molecule recruited to cadherin-based adherens junctions through interaction with afadin, a PDZ domain-containing protein. J. Cell Biol. 145, 539–545 (1999).
doi: 10.1083/jcb.145.3.539
Satoh-Horikawa, K. et al. Nectin-3, a new member of immunoglobulin-like cell adhesion molecules that shows homophilic and heterophilic cell-cell adhesion activities. J. Biol. Chem. 275, 10291–10299 (2000).
doi: 10.1074/jbc.275.14.10291
Tachibana, K. et al. Two cell adhesion molecules, nectin and cadherin, interact through their cytoplasmic domain-associated proteins. J. Cell Biol. 150, 1161–1176 (2000).
doi: 10.1083/jcb.150.5.1161
Beroukhim, R. et al. Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma. Proc. Natl Acad. Sci. USA 104, 20007–20012 (2007).
doi: 10.1073/pnas.0710052104
Akbani, R. et al. Genomic classification of cutaneous melanoma. Cell 161, 1681–1696 (2015).
doi: 10.1016/j.cell.2015.05.044
Ablain, J., Durand, E. M., Yang, S., Zhou, Y. & Zon, L. I. A CRISPR/Cas9 vector system for tissue-specific gene disruption in zebrafish. Dev. Cell 32, 756–764 (2015).
doi: 10.1016/j.devcel.2015.01.032
Ablain, J. et al. Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma. Science 362, 1055–1060 (2018).
doi: 10.1126/science.aau6509
Fazio, M. et al. Satb2 induction of a neural crest mesenchyme-like program drives melanoma invasion and drug resistance. Elife 10, e64370 (2021).
doi: 10.7554/eLife.64370
Heilmann, S. et al. A quantitative system for studying metastasis using transparent zebrafish. Cancer Res. 75, 4272–4282 (2015).
doi: 10.1158/0008-5472.CAN-14-3319
Tsoi, J. et al. Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative Stress. Cancer Cell 33, 890–904 (2018).
doi: 10.1016/j.ccell.2018.03.017
Sato, T. et al. Regulation of the assembly and adhesion activity of E-cadherin by nectin and afadin for the formation of adherens junctions in Madin-Darby canine kidney cells. J. Biol. Chem. 281, 5288–5299 (2006).
doi: 10.1074/jbc.M510070200
Arozarena, I. & Wellbrock, C. Phenotype plasticity as enabler of melanoma progression and therapy resistance. Nat. Rev. Cancer 19, 377–391 (2019).
doi: 10.1038/s41568-019-0154-4
Humphries, J. D., Byron, A. & Humphries, M. J. Integrin ligands at a glance. J. Cell Sci. 119, 3901–3903 (2006).
doi: 10.1242/jcs.03098
Carboni, J. M. et al. Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor. Cancer Res. 65, 3781–3787 (2005).
doi: 10.1158/0008-5472.CAN-04-4602
Satyamoorthy, K. et al. Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and β-catenin pathways. Cancer Res. 61, 7318–7324 (2001).
Sakamoto, Y. et al. Interaction of integrin αvβ3 with nectin: Implication in cross-talk between cell-matrix and cell-cell junctions. J. Biol. Chem. 281, 19631–19644 (2006).
doi: 10.1074/jbc.M600301200
Lopez, T. & Hanahan, D. Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis. Cancer Cell 1, 339–353 (2002).
doi: 10.1016/S1535-6108(02)00055-7
Castaño, Z. et al. Stromal EGF and IGF-I together modulate plasticity of disseminated triple-negative breast tumors. Cancer Discov. 3, 922–935 (2013).
doi: 10.1158/2159-8290.CD-13-0041
Le Coz, V. et al. IGF-1 contributes to the expansion of melanoma-initiating cells through an epithelial-mesenchymal transition process. Oncotarget 7, 82511–82527 (2016).
doi: 10.18632/oncotarget.12733
Gupta, G. P. & Massagué, J. Cancer metastasis: Building a framework. Cell 127, 679–695 (2006).
doi: 10.1016/j.cell.2006.11.001
White, R. M. et al. DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature 471, 518–522 (2011).
doi: 10.1038/nature09882
Kaufman, C. K. et al. A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation. Science 351, aad2197 (2016).
doi: 10.1126/science.aad2197
Suzuki, K. et al. Mutations of PVRL1, encoding a cell-cell adhesion molecule/herpesvirus receptor, in cleft lip/palate-ectodermal dysplasia. Nat. Genet. 25, 427–430 (2000).
doi: 10.1038/78119
Ciarlo, C. et al. A chemical screen in zebrafish embryonic cells establishes that Akt activation is required for neural crest development. Elife 6, e29145 (2017).
doi: 10.7554/eLife.29145
Li, G., Satyamoorthy, K. & Herlyn, M. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res. 61, 3819–3825 (2001).
Piskounova, E. et al. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature 527, 186–191 (2015).
doi: 10.1038/nature15726
Konieczkowski, D. J. et al. A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors. Cancer Discov. 4, 816–827 (2014).
doi: 10.1158/2159-8290.CD-13-0424
Ahn, S., Woo, J. W., Lee, K. & Park, S. Y. HER2 status in breast cancer: Changes in guidelines and complicating factors for interpretation. J. Pathol. Transl. Med. 54, 34–44 (2020).
doi: 10.4132/jptm.2019.11.03
Kawakami, K. et al. A transposon-mediated gene trap approach identifies developmentally regulated genes in zebrafish. Dev. Cell 7, 133–144 (2004).
doi: 10.1016/j.devcel.2004.06.005
Shalem, O. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84–87 (2014).
doi: 10.1126/science.1247005
Hartley, J. L., Temple, G. F. & Brasch, M. A. DNA cloning using in vitro site-specific recombination. Genome Res. 10, 1788–1795 (2000).
doi: 10.1101/gr.143000
Ceol, C. J. et al. The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature 471, 513–517 (2011).
doi: 10.1038/nature09806
White, R. M. et al. Transparent adult zebrafish as a tool for in vivo transplantation analysis. Cell Stem Cell 2, 183–189 (2008).
doi: 10.1016/j.stem.2007.11.002
Berdyyeva, T. K., Woodworth, C. D. & Sokolov, I. Human epithelial cells increase their rigidity with ageing in vitro: Direct measurements. Phys. Med. Biol. 50, 81 (2005).
doi: 10.1088/0031-9155/50/1/007
Guz, N., Dokukin, M., Kalaparthi, V. & Sokolov, I. If cell mechanics can be described by elastic modulus: Study of different models and probes used in indentation experiments. Biophys. J. 107, 564–575 (2014).
doi: 10.1016/j.bpj.2014.06.033
A-Hassan, E. et al. Relative microelastic mapping of living cells by atomic force microscopy. Biophys. J. 74, 1564–1578 (1998).
doi: 10.1016/S0006-3495(98)77868-3
Sokolov, I., Zorn, G. & Nichols, J. M. A study of molecular adsorption of a cationic surfactant on complex surfaces with atomic force microscopy. Analyst 141, 1017–1026 (2016).
doi: 10.1039/C5AN01941A
Dokukin, M. E. & Sokolov, I. On the measurements of rigidity modulus of soft materials in nanoindentation experiments at small depth. Macromolecules 45, 4277–4288 (2012).
doi: 10.1021/ma202600b
Trapnell, C. et al. Transcript assembly and abundance estimation from RNA-Seq reveals thousands of new transcripts and switching among isoforms. Nat. Biotechnol. 28, 511–515 (2011).
doi: 10.1038/nbt.1621
Ashburner, M. et al. Gene ontology: Tool for the unification of biology. Nat. Genet. 25, 25–29 (2000).
doi: 10.1038/75556
Carbon, S. et al. The Gene Ontology Resource: 20 years and still GOing strong. Nucleic Acids Res. 47, D330–D338 (2019).
doi: 10.1093/nar/gky1055
Mootha, V. K. et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267–273 (2003).
doi: 10.1038/ng1180
Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).
doi: 10.1073/pnas.0506580102

Auteurs

Julien Ablain (J)

Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, INSERM U1052 CNRS UMR5286, Lyon, France. julien.ablain@lyon.unicancer.fr.
Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Boston, MA, USA. julien.ablain@lyon.unicancer.fr.

Amira Al Mahi (A)

Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, INSERM U1052 CNRS UMR5286, Lyon, France.

Harriet Rothschild (H)

Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Boston, MA, USA.

Meera Prasad (M)

Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Boston, MA, USA.

Sophie Aires (S)

Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, INSERM U1052 CNRS UMR5286, Lyon, France.

Song Yang (S)

Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Boston, MA, USA.

Maxim E Dokukin (ME)

Department of Mechanical Engineering and Department of Biomedical Engineering, Tufts University, Medford, MA, USA.
Sarov Physics and Technology Institute, National Research Nuclear University MEPhI, Sarov, Russian Federation.

Shuyun Xu (S)

Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.

Michelle Dang (M)

Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Boston, MA, USA.

Igor Sokolov (I)

Department of Mechanical Engineering and Department of Biomedical Engineering, Tufts University, Medford, MA, USA.

Christine G Lian (CG)

Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.

Leonard I Zon (LI)

Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Boston, MA, USA.
Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA.
Howard Hughes Medical Institute, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH